The effects of estrogen on targeted cancer therapy drugs

Improving the efficacy of anticancer drugs is especially challenging. Estrogen is a sex hormone that not only promotes the development of female secondary sexual characteristics, but also supports many important physiological functions. Interestingly, estrogen has shown to be vital for the activity...

Full description

Bibliographic Details
Main Authors: Ying Zhao, Xin Wang, Yi Liu, Hao-Yu Wang, Jin Xiang
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661822000767
_version_ 1797366693153996800
author Ying Zhao
Xin Wang
Yi Liu
Hao-Yu Wang
Jin Xiang
author_facet Ying Zhao
Xin Wang
Yi Liu
Hao-Yu Wang
Jin Xiang
author_sort Ying Zhao
collection DOAJ
description Improving the efficacy of anticancer drugs is especially challenging. Estrogen is a sex hormone that not only promotes the development of female secondary sexual characteristics, but also supports many important physiological functions. Interestingly, estrogen has shown to be vital for the activity of some anticancer drugs, such as adriamycin, cisplatin, olaparib, trastuzumab, bevacizumab, tamoxifen, cyclophosphamide, methotrexate, and paclitaxel. Although there are many reasons for the differences in therapeutic effects among cancer patients, estrogen status is undoubtedly a very important factor. In view of the importance of the crosstalk between estrogen signaling and drug therapy for cancer, this review summarizes the effects of estrogen on the targets, metabolism and resistance of anticancer drugs and describes the related pathways and underlying mechanisms. Here, an analysis of the close relationship between estrogen and cancer drug therapy was conducted to clarify the effects of estrogen on the therapeutic efficacy of anticancer drugs to facilitate the future development of specific drug treatment strategies to achieve optimal outcomes.
first_indexed 2024-03-08T17:07:22Z
format Article
id doaj.art-dfd617f9996847eba67ee2739243b9bf
institution Directory Open Access Journal
issn 1096-1186
language English
last_indexed 2024-03-08T17:07:22Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj.art-dfd617f9996847eba67ee2739243b9bf2024-01-04T04:36:31ZengElsevierPharmacological Research1096-11862022-03-01177106131The effects of estrogen on targeted cancer therapy drugsYing Zhao0Xin Wang1Yi Liu2Hao-Yu Wang3Jin Xiang4Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, PR ChinaKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, PR ChinaKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, PR ChinaKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, PR ChinaCorresponding author.; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, PR ChinaImproving the efficacy of anticancer drugs is especially challenging. Estrogen is a sex hormone that not only promotes the development of female secondary sexual characteristics, but also supports many important physiological functions. Interestingly, estrogen has shown to be vital for the activity of some anticancer drugs, such as adriamycin, cisplatin, olaparib, trastuzumab, bevacizumab, tamoxifen, cyclophosphamide, methotrexate, and paclitaxel. Although there are many reasons for the differences in therapeutic effects among cancer patients, estrogen status is undoubtedly a very important factor. In view of the importance of the crosstalk between estrogen signaling and drug therapy for cancer, this review summarizes the effects of estrogen on the targets, metabolism and resistance of anticancer drugs and describes the related pathways and underlying mechanisms. Here, an analysis of the close relationship between estrogen and cancer drug therapy was conducted to clarify the effects of estrogen on the therapeutic efficacy of anticancer drugs to facilitate the future development of specific drug treatment strategies to achieve optimal outcomes.http://www.sciencedirect.com/science/article/pii/S1043661822000767EstrogenAnticancer drugsEstrogen receptorsMetabolismPrecision therapyResistance
spellingShingle Ying Zhao
Xin Wang
Yi Liu
Hao-Yu Wang
Jin Xiang
The effects of estrogen on targeted cancer therapy drugs
Pharmacological Research
Estrogen
Anticancer drugs
Estrogen receptors
Metabolism
Precision therapy
Resistance
title The effects of estrogen on targeted cancer therapy drugs
title_full The effects of estrogen on targeted cancer therapy drugs
title_fullStr The effects of estrogen on targeted cancer therapy drugs
title_full_unstemmed The effects of estrogen on targeted cancer therapy drugs
title_short The effects of estrogen on targeted cancer therapy drugs
title_sort effects of estrogen on targeted cancer therapy drugs
topic Estrogen
Anticancer drugs
Estrogen receptors
Metabolism
Precision therapy
Resistance
url http://www.sciencedirect.com/science/article/pii/S1043661822000767
work_keys_str_mv AT yingzhao theeffectsofestrogenontargetedcancertherapydrugs
AT xinwang theeffectsofestrogenontargetedcancertherapydrugs
AT yiliu theeffectsofestrogenontargetedcancertherapydrugs
AT haoyuwang theeffectsofestrogenontargetedcancertherapydrugs
AT jinxiang theeffectsofestrogenontargetedcancertherapydrugs
AT yingzhao effectsofestrogenontargetedcancertherapydrugs
AT xinwang effectsofestrogenontargetedcancertherapydrugs
AT yiliu effectsofestrogenontargetedcancertherapydrugs
AT haoyuwang effectsofestrogenontargetedcancertherapydrugs
AT jinxiang effectsofestrogenontargetedcancertherapydrugs